U.S. Taxpayers Fuel Moderna’s COVID-19 Vaccine
As funders of the vaccine, Americans must have transparency and a say in the price
PRESS RELEASE: A “Not-For-Profit” Vaccine From Johnson & Johnson?
Johnson & Johnson stands to turn a pandemic into a payday at the expense of taxpayers.
A Not-For-Profit Vaccine From Johnson & Johnson? Not so fast.
Upon closer look, J&J stands to profit handsomely.
AXIOS: Drugmaker tripled the price of a pill as it pursued coronavirus use
"The price hike coincides with the company's push to get its drug to more patients — specifically those diagnosed with COVID-19."
Drug Corporations Didn’t Invest in Vaccines Until a Global Pandemic
Drug companies only showed interest in COVID-19 vaccines and treatments when huge profits arose.
Statement: Public-Private Partnership to Drive COVID-19 Research Overlooks Drug Prices
The federal government will be the single largest investor and the largest purchaser of an upcoming COVID-19 vaccine or treatment.
Tracking COVID-19 Funds: How U.S. Taxpayers Are Investing in Vaccines and Treatments
In just one week, U.S. taxpayers gave more than $700 million to pharma for COVID-19 research and development.
Patients Call On Insulin Manufacturers To Respond To Covid-19 Pandemic And Lower List Prices
Patients For Affordable Drugs and 63 people living with diabetes penned a letter to the Big 3 insulin manufacturers urging them to take action to lower the list prices of their insulin products immediately.
